Onconova Therapeutics, Inc.·4

Nov 30, 5:09 PM ET

OLER ABRAHAM N. 4

4 · Onconova Therapeutics, Inc. · Filed Nov 30, 2020

Insider Transaction Report

Form 4
Period: 2020-11-25
OLER ABRAHAM N.
VP Corp Dev & Gen Counsel
Transactions
  • Purchase

    Common Stock

    2020-11-25$0.26/sh+20,000$5,120110,000 total
Footnotes (1)
  • [F1]Includes 35,000 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -